Bone mass development and bone metabolism in juvenile idiopathic arthritis: treatment with growth hormone for 4 years

Susanne Bechtold1, Peter Ripperger, Walter Bonfig

  • 1Endocrine Division, University Children's Hospital, Dr. von Haunersches Kinderspital, Lindwurmstrasse 4, 80337 Munich, Germany. Susanne.Bechtold@med.uni-muenchen.de

Insights

Growth hormone (GH) therapy in children with juvenile idiopathic arthritis (JIA) increased bone turnover and stabilized volumetric bone mineral density (vBMD) over four years. Long-term studies are needed to confirm GH

Area of Science:

  • Pediatric Endocrinology
  • Rheumatology
  • Bone Metabolism

Background:

  • Juvenile idiopathic arthritis (JIA) can affect bone mass acquisition.
  • Growth hormone (GH) therapy is used in pediatric conditions, but its effect on bone density in JIA is not fully understood.

Purpose of the Study:

  • To longitudinally assess bone mass and bone mineral density (BMD) changes in children with JIA undergoing GH therapy.
  • To compare bone acquisition in JIA patients with healthy children.

Main Methods:

  • Dual-energy x-ray absorptiometry (DXA) was used to measure bone mineral content (BMC) and BMD.
  • Volumetric BMD (vBMD) was calculated after adjusting for vertebral size.
  • Measurements were taken over 4 years in 11 children with JIA.

Main Results:

  • Children with JIA had low BMD at baseline (mean aBMD z-score -2.04).
  • Four years of GH treatment significantly increased vBMD (p < 0.03) and bone turnover markers.
  • vBMD changes relative to age and bone age were comparable to healthy children.

Conclusions:

  • GH therapy increases bone turnover in children with JIA.
  • vBMD stabilized during GH treatment, showing potential for bone density improvement.
  • Long-term GH treatment efficacy on bone density and metabolism in JIA requires further investigation.
Abstract

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K
Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
3.9K
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
3.3K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
7.7K
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
9.7K